RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Microbix Biosystems Stock

Microbix Biosystems Revenue 2024

Microbix Biosystems Revenue

25.45 M CAD

Ticker

MBX.TO

ISIN

CA59501P1045

WKN

935162

In 2024, Microbix Biosystems's sales reached 25.45 M CAD, a 54.16% difference from the 16.51 M CAD sales recorded in the previous year.

The Microbix Biosystems Revenue history

YEARREVENUE (undefined CAD)GROSS MARGIN (%)
2026e39.5918,89
2025e29.3925,45
2024e25.4529,39
202316.5145,31
202219.0858,28
202118.5959,39
202010.5244,30
201913.4148,84
201812.5142,93
201710.1947,20
20169.5252,31
20158.8765,84
20148.453,69
20137.5750,59
20126.6741,23
20116.2344,94
20106.4657,74
20096.0858,55
20084.9950,30
20074.0547,65
20063.6551,78
20054.3861,64
20044.0763,39

Microbix Biosystems Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Microbix Biosystems, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Microbix Biosystems from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Microbix Biosystems’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Microbix Biosystems. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Microbix Biosystems’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Microbix Biosystems’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Microbix Biosystems’s growth potential.

Microbix Biosystems Revenue, EBIT and net profit per share

DateMicrobix Biosystems RevenueMicrobix Biosystems EBITMicrobix Biosystems Net Income
2026e39.59 M CAD17.47 M CAD6.89 M CAD
2025e29.39 M CAD9.81 M CAD2.76 M CAD
2024e25.45 M CAD8.16 M CAD2.76 M CAD
202316.51 M CAD-2.74 M CAD-40,000 CAD
202219.08 M CAD2.61 M CAD1.79 M CAD
202118.59 M CAD4.82 M CAD3.23 M CAD
202010.52 M CAD-560,000 CAD-6.23 M CAD
201913.41 M CAD1.03 M CAD30,000 CAD
201812.51 M CAD80,000 CAD-740,000 CAD
201710.19 M CAD-650,000 CAD-3.78 M CAD
20169.52 M CAD830,000 CAD750,000 CAD
20158.87 M CAD1.09 M CAD610,000 CAD
20148.4 M CAD1.31 M CAD170,000 CAD
20137.57 M CAD730,000 CAD0 CAD
20126.67 M CAD-1.69 M CAD-2.39 M CAD
20116.23 M CAD-1.66 M CAD-2.57 M CAD
20106.46 M CAD-1.65 M CAD-2.54 M CAD
20096.08 M CAD-1.9 M CAD-2.48 M CAD
20084.99 M CAD-3.49 M CAD-3.67 M CAD
20074.05 M CAD-2.34 M CAD-2.71 M CAD
20063.65 M CAD-1.9 M CAD-2.09 M CAD
20054.38 M CAD300,000 CAD120,000 CAD
20044.07 M CAD90,000 CAD10,000 CAD

Microbix Biosystems stock margins

The Microbix Biosystems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Microbix Biosystems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Microbix Biosystems.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Microbix Biosystems's sales revenue. A higher gross margin percentage indicates that the Microbix Biosystems retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Microbix Biosystems's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Microbix Biosystems's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Microbix Biosystems's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Microbix Biosystems. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Microbix Biosystems's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Microbix Biosystems Margin History

Microbix Biosystems Gross marginMicrobix Biosystems Profit marginMicrobix Biosystems EBIT marginMicrobix Biosystems Profit margin
2026e45.31 %44.13 %17.4 %
2025e45.31 %33.37 %9.38 %
2024e45.31 %32.07 %10.83 %
202345.31 %-16.6 %-0.24 %
202258.28 %13.68 %9.38 %
202159.39 %25.93 %17.37 %
202044.3 %-5.32 %-59.22 %
201948.84 %7.68 %0.22 %
201842.93 %0.64 %-5.92 %
201747.2 %-6.38 %-37.1 %
201652.31 %8.72 %7.88 %
201565.84 %12.29 %6.88 %
201453.69 %15.6 %2.02 %
201350.59 %9.64 %0 %
201241.23 %-25.34 %-35.83 %
201144.94 %-26.65 %-41.25 %
201057.74 %-25.54 %-39.32 %
200958.55 %-31.25 %-40.79 %
200850.3 %-69.94 %-73.55 %
200747.65 %-57.78 %-66.91 %
200651.78 %-52.05 %-57.26 %
200561.64 %6.85 %2.74 %
200463.39 %2.21 %0.25 %

Microbix Biosystems Aktienanalyse

What does Microbix Biosystems do?

Microbix Biosystems Inc. is a Canadian company specializing in the development and marketing of biological products and solutions in various industries. The company was founded in 1988 and is headquartered in Toronto, Ontario. Microbix Biosystems ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Microbix Biosystems's Sales Figures

The sales figures of Microbix Biosystems originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Microbix Biosystems’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Microbix Biosystems's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Microbix Biosystems’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Microbix Biosystems stock

How much revenue did Microbix Biosystems generate this year?

Microbix Biosystems has achieved a revenue of 25.45 M CAD this year.

How much was the turnover of the company Microbix Biosystems compared to the previous year?

The revenue of Microbix Biosystems has increased by 54.16% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Microbix Biosystems?

The revenue of Microbix Biosystems is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Microbix Biosystems measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Microbix Biosystems so important for investors?

The revenue of Microbix Biosystems is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Microbix Biosystems pay?

Over the past 12 months, Microbix Biosystems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Microbix Biosystems is expected to pay a dividend of 0 CAD.

What is the dividend yield of Microbix Biosystems?

The current dividend yield of Microbix Biosystems is .

When does Microbix Biosystems pay dividends?

Microbix Biosystems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Microbix Biosystems?

Microbix Biosystems paid dividends every year for the past 0 years.

What is the dividend of Microbix Biosystems?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Microbix Biosystems located?

Microbix Biosystems is assigned to the 'Health' sector.

Wann musste ich die Aktien von Microbix Biosystems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Microbix Biosystems from 9/16/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did Microbix Biosystems pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Microbix Biosystems in the year 2023?

In the year 2023, Microbix Biosystems distributed 0 CAD as dividends.

In which currency does Microbix Biosystems pay out the dividend?

The dividends of Microbix Biosystems are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Microbix Biosystems

Our stock analysis for Microbix Biosystems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Microbix Biosystems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.